- This PRISMA-ScR scoping review screened 2,187 records and included 12 studies of ketamine with pain and depression outcomes assessed longitudinally.
- Eight studies enrolled chronic pain patients and four enrolled depression-primary populations, while acute, perioperative, perinatal, and cancer-related pain were excluded.
- Most studies reported concurrent improvement in pain and depressive symptoms, but the abstract gives no pooled effect size.
- The authors conclude that heterogeneity in populations, dosing, design, and comorbidity prevents inferring that depression modifies ketamine's analgesic effect, and call for randomized trials.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This systematic scoping review screened 4,344 records and included 29 unique studies (21 articles and 12 protocols) of mHealth interventions for adults with chronic non-cancer pain.
- Included interventions were mainly mobile apps (n = 14), followed by text messaging (n = 5) and telephone interactive voice response (n = 3).
- Opioid use was an eligibility criterion in 14 studies, and seven were designed specifically to support opioid tapering.
- Published results reported high acceptability and feasibility with potential efficacy, and the authors call for future studies to evaluate efficacy and mediating or moderating factors.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- This narrative review synthesises mechanistic evidence from human tissue analyses, advanced neuroimaging, and deep clinical phenotyping in entrapment neuropathies, the most prevalent focal neuropathic pain conditions.
- The authors describe these disorders as biologically dynamic, involving microvascular compromise, demyelination, axonal degeneration, immune dysregulation, neuroinflammation, central adaptations, and psychosocial influences.
- Varying combinations of these processes are proposed to explain clinical heterogeneity within one diagnosis and discordances such as normal electrodiagnostic findings or imaging-symptom mismatch.
- The authors argue that surgical decompression offers a natural model of focal nerve injury and that mechanism-informed management may be needed, since one-size-fits-all treatments have largely failed.
- This perspective article proposes a conceptual framework for pediatric chronic pain research and care, rather than reporting new empirical data.
- The BRIDGE framework combines biobehavioral mechanistic research with digital monitoring, such as wearable sensors and ecological momentary assessment, and guided patient engagement.
- The authors argue that these tools could identify modifiable mechanisms, digital biomarkers of risk and recovery, and support precision and adaptive treatment.
- They emphasize that partnership with youth and families is central, so that measurement and interventions stay aligned with patient priorities and lived experience.
- This is a narrative review by a pain researcher accepting a 2026 lifetime achievement prize, summarizing four decades of animal-model work.
- It covers gene expression changes related to neuroplasticity in dorsal root ganglion and spinal cord, using morphological, molecular, behavioral, and electrophysiological methods.
- The abstract reports no quantitative results, effect sizes, or statistics; it describes the scope of the review and planned discussion of methods and future directions.
- This invited viewpoint synthesizes contributors to pain inequity in low- and middle-income countries and among cultural minority groups in high-income settings.
- Proposed remedies include education of health professionals and the public, culturally and linguistically responsive assessment, contextually adapted self-management, and standardized collection of sociodemographic data.
- The author proposes principles for North-South collaboration, including co-created research agendas, shared leadership, sustainable capacity building, and transparent governance.
- The conclusion calls for coordinated action across clinicians, researchers, institutions, policymakers, journals, funders, and communities.
- This article is a discussion piece on neuropathic pain, not a primary study, so it reports no trial data or effect sizes.
- It argues that heterogeneous neuropathic pain mechanisms, not only etiology, may explain repeated trial failures and suggests mechanism-based reclassification.
- It notes that no validated biomarkers for pain mechanisms currently exist, so it discusses surrogate markers such as patient-reported sensory symptoms and sensory testing.
- The authors propose integrating these candidate predictive and surrogate markers into future clinical trials to identify likely treatment responders.
- This narrative review synthesizes work on human nociceptor diversity, linking microneurography, patch-clamp electrophysiology, and single-cell transcriptomics.
- It discusses transferring microneurography hallmarks, such as activity-dependent slowing and recovery cycles, into in vitro patch-clamp paradigms, with Patch-seq assigning molecular identity to functional subtypes.
- The mechano-insensitive 'sleeping' nociceptor is offered as an example of a functionally defined subtype characterized molecularly.
- The authors argue that integrating human nerve fiber function with molecular programs, including sodium channel subtypes, could enable stratified, mechanism-based neuropathic pain therapies.
- This is an updated perspective article reviewing how exercise may act on the mesocorticolimbic system in chronic pain.
- It proposes three routes: myokines such as IGF-1 acting through orexin and VTA dopamine neurons, amygdala circuits, and dorsal raphe serotonin neurons.
- No sample sizes, effect sizes, or confidence intervals are reported, so the supporting evidence is described only qualitatively.
- The authors conclude that exercise therapy should be a key component of chronic pain management, and propose epigenetic changes as a basis for lasting effects.
- This review examines drug combination therapy for pain, drawing on preclinical synergy studies, real-world prescribing data, and many randomized trials across several pain conditions.
- Combining drugs from different mechanistic classes is proposed to give superior analgesia and possibly fewer side effects than monotherapy, based on preclinical synergy.
- Real-world data reportedly show that about half of patients with chronic pain, and more with acute pain, receive two or more drugs from different classes.
- The authors argue that many analgesic combinations lack rigorous evidence and propose five priorities, including trials that compare each monotherapy component.
- This perspective article synthesizes pharmacology, neural recording, and causal manipulation evidence on spontaneous neuropathic pain and presents no original sample or data.
- It describes injured-fiber ectopic activity in specific sensory neuron subtypes as a dominant peripheral generator of spontaneous pain, separate from spared-fiber pathways that drive evoked hypersensitivity.
- The authors argue spontaneous neuropathic pain should be defined as its own symptom domain, because most therapies were validated on evoked or overall intensity endpoints.
- They propose longitudinal, biomarker-informed phenotyping to capture fluctuating pain and support mechanism-based, symptom-aligned treatments.
- This is a translational review combining clinical evidence and preclinical mechanistic models on postsurgical pain prediction and prevention.
- It covers perioperative bio-psycho-social risk factors for acute-to-chronic postsurgical pain, plus emerging biological signatures for risk stratification.
- The authors argue that current risk assessment tools lack sufficient precision, reliability, and generalizability, and that risk evolves across pre-, intra-, and postsurgical phases.
- They propose integrating bio-psycho-social factors into clinically relevant prognostic models to support mechanism-based, personalized prevention in vulnerable patients.
- This narrative review synthesizes animal and human studies on the brain sites involved in endogenous pain modulation.
- It focuses on the best-characterised pathway, running from the midbrain periaqueductal gray to the rostral ventromedial medulla and then to the dorsal horn or spinal trigeminal nucleus.
- These circuits are conserved and can modulate pain largely independently of cortex, though the prefrontal cortex can influence them, and their organisation may change in persistent pain.
- Ultra-high-field fMRI now allows imaging of brainstem nuclei at millimetre-cubed scale, which standard MRI's limited resolution had previously prevented.
- This paper summarises the ENTRUST-PE framework, developed by an international, interdisciplinary network to enhance trustworthiness in pain research.
- The framework proposes seven core values, including methodological rigour, openness and transparency, and patient and public involvement, with recommendations for different interest holders.
- The authors reflect on the community's response since the 2024 launch and consider challenges and opportunities in the evolving research landscape.
- They suggest how the field might move toward deeper implementation of the framework.
- This narrative review synthesizes mechanistic work on chloride dysregulation in chronic pain, and the abstract reports no sample size or clinical data.
- It focuses on injury-induced downregulation of the potassium-chloride cotransporter KCC2 in spinal dorsal horn neurons as a substrate for loss of spinal inhibition.
- The authors argue that chloride dysregulation could explain neuropathic pain features such as hyperalgesia, allodynia, and spontaneous pain, and could account for benzodiazepine analgesic failure.
- They conclude that KCC2 is a promising novel target for both analgesia and disease modification in chronic pain.
- Systematic review and meta-analysis of 8 randomized controlled trials including 543 adults, comparing short-term peripheral nerve stimulation with sham or usual care.
- The primary outcome was change in average pain intensity during the implantation period.
- Average pain fell during implantation at 1-4 weeks (SMD -0.48, 95% CI -0.71 to -0.26) and 5-8 weeks (SMD -0.96, 95% CI -1.22 to -0.70), but not after electrode removal.
- The authors describe the evidence as preliminary: pain relief occurs during implantation, but not all outcomes show benefit that persists after removal.